Atherectomy devices were developed as a mechanism of physically removing plaque from the lesion itself. The first two devices invented were the directional atherectomy device and the transluminal extraction catheter (TEC). In the early 1980’s David Auth investigated the use of a rotational device as a mechanical alternative in debulking atherosclerotic plaque. 1
The first studies were performed in canine arteries, followed in January 1988 in human coronary arteries. 2, 3 This rotational atherectomy system, known as Rotablator® was commercialised by Heart Technology, received FDA approval in 1990 for use in peripheral arteries, and in 1993 for coronary arteries. It was subsequently acquired by Boston Scientific (Natick, MA, USA) in 1996, who continue to market...Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com